1-26913429-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021969.3(NR0B2):c.512G>C(p.Gly171Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0716 in 1,613,920 control chromosomes in the GnomAD database, including 4,438 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.067 ( 375 hom., cov: 32)
Exomes 𝑓: 0.072 ( 4063 hom. )
Consequence
NR0B2
NM_021969.3 missense
NM_021969.3 missense
Scores
2
7
9
Clinical Significance
Conservation
PhyloP100: 3.90
Publications
43 publications found
Genes affected
NR0B2 (HGNC:7961): (nuclear receptor subfamily 0 group B member 2) The protein encoded by this gene is an unusual orphan receptor that contains a putative ligand-binding domain but lacks a conventional DNA-binding domain. The gene product is a member of the nuclear hormone receptor family, a group of transcription factors regulated by small hydrophobic hormones, a subset of which do not have known ligands and are referred to as orphan nuclear receptors. The protein has been shown to interact with retinoid and thyroid hormone receptors, inhibiting their ligand-dependent transcriptional activation. In addition, interaction with estrogen receptors has been demonstrated, leading to inhibition of function. Studies suggest that the protein represses nuclear hormone receptor-mediated transactivation via two separate steps: competition with coactivators and the direct effects of its transcriptional repressor function. [provided by RefSeq, Jul 2008]
NUDC (HGNC:8045): (nuclear distribution C, dynein complex regulator) This gene encodes a nuclear distribution protein that plays an essential role in mitosis and cytokinesis. The encoded protein is involved in spindle formation during mitosis and in microtubule organization during cytokinesis. Pseudogenes of this gene are found on chromosome 2. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006049454).
BP6
Variant 1-26913429-C-G is Benign according to our data. Variant chr1-26913429-C-G is described in ClinVar as Benign. ClinVar VariationId is 595423.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0767 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NR0B2 | ENST00000254227.4 | c.512G>C | p.Gly171Ala | missense_variant | Exon 1 of 2 | 1 | NM_021969.3 | ENSP00000254227.3 | ||
| NUDC | ENST00000435827.6 | c.93+2194C>G | intron_variant | Intron 3 of 6 | 5 | ENSP00000404020.2 |
Frequencies
GnomAD3 genomes AF: 0.0670 AC: 10184AN: 152008Hom.: 374 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
10184
AN:
152008
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0592 AC: 14861AN: 251016 AF XY: 0.0594 show subpopulations
GnomAD2 exomes
AF:
AC:
14861
AN:
251016
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0721 AC: 105376AN: 1461794Hom.: 4063 Cov.: 32 AF XY: 0.0711 AC XY: 51683AN XY: 727204 show subpopulations
GnomAD4 exome
AF:
AC:
105376
AN:
1461794
Hom.:
Cov.:
32
AF XY:
AC XY:
51683
AN XY:
727204
show subpopulations
African (AFR)
AF:
AC:
2161
AN:
33480
American (AMR)
AF:
AC:
1435
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
1319
AN:
26134
East Asian (EAS)
AF:
AC:
80
AN:
39700
South Asian (SAS)
AF:
AC:
3705
AN:
86252
European-Finnish (FIN)
AF:
AC:
4083
AN:
53418
Middle Eastern (MID)
AF:
AC:
247
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
88388
AN:
1111924
Other (OTH)
AF:
AC:
3958
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
5000
10000
14999
19999
24999
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3200
6400
9600
12800
16000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0670 AC: 10189AN: 152126Hom.: 375 Cov.: 32 AF XY: 0.0663 AC XY: 4932AN XY: 74378 show subpopulations
GnomAD4 genome
AF:
AC:
10189
AN:
152126
Hom.:
Cov.:
32
AF XY:
AC XY:
4932
AN XY:
74378
show subpopulations
African (AFR)
AF:
AC:
2536
AN:
41502
American (AMR)
AF:
AC:
860
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
160
AN:
3470
East Asian (EAS)
AF:
AC:
19
AN:
5172
South Asian (SAS)
AF:
AC:
217
AN:
4820
European-Finnish (FIN)
AF:
AC:
876
AN:
10586
Middle Eastern (MID)
AF:
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5332
AN:
67992
Other (OTH)
AF:
AC:
123
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
481
962
1444
1925
2406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
328
ALSPAC
AF:
AC:
303
ESP6500AA
AF:
AC:
272
ESP6500EA
AF:
AC:
699
ExAC
AF:
AC:
7461
Asia WGS
AF:
AC:
138
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
Dec 19, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Pathogenic
D
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
D
Vest4
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.